India now offers Awiqli, a new once-weekly basal insulin for diabetes patients. This drug reduces annual injections from 365 to just 52 for many individuals. Experts suggest Awiqli is an additional option, not a complete replacement for daily insulin. It is best suited for patients who still produce some insulin naturally. This innovation aims to improve treatment adherence and manage blood sugar levels effectively.

Novo Nordisk is set to introduce Awiqli, an innovative once-weekly insulin, in India shortly. This remarkable treatment drastically cuts down the number of insulin injections from…

Novo Nordisk has launched Awiqli, a new weekly basal insulin injection, in India. This innovative drug offers a once-weekly alternative to daily injections for diabetes patients.…

The product will be imported from Denmark and is priced at ₹2611 for a 1 ml pen (700 insulin units)

The injection replaces the need for a daily basal insulin injection with a once-a-week dose. This reduces the annual number of injections from 365 to just 52. | India News

Novo Nordisk launches Awiqli, the world's first once-weekly insulin, in India to revolutionize diabetes management.

Awiqli is a new insulin injection that needs to be administered only once a week. Learn from a doctor about benefits, side effects, and dosage. | Health

India now offers Awiqli, a new once-weekly basal insulin for diabetes patients. This drug reduces annual injections from 365 to just 52 for many individuals. Experts suggest…